Literature DB >> 9740395

Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures.

C Czech1, M Lesort, G Tremp, F Terro, V Blanchard, B Schombert, N Carpentier, S Dreisler, B Bonici, A Takashima, S Moussaoui, J Hugon, L Pradier.   

Abstract

Mutations in the gene for presenilin 1 are causative for the majority of cases of early onset familial Alzheimer's disease. Yet, the physiological function of presenilin 1 and the pathological mechanisms of the mutations leading to Alzheimer's disease are still unknown. To analyse potential pathological effects of presenilin 1 over-expression, we have generated transgenic rats which express high levels of human presenilin 1 protein in the brain. The over-expression of presenilin 1 leads to saturation of its normal processing and to the appearance of full-length protein in the transgenic rat brain. The transgenic protein is expressed throughout the brain and is predominantly found in neuronal cells. Cultured primary cortical neurons derived from these transgenic rats are significantly more sensitive than non-transgenic controls to apoptosis induced by standard culture conditions and to apoptosis induced by trophic factor withdrawal. Furthermore, the observed apoptosis is directly correlated with the expression of the transgenic protein. The results further emphasize the role of presenilin 1 in apoptotic cell death in native neuronal cultures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740395     DOI: 10.1016/s0306-4522(98)00162-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.

Authors:  Y Hashimoto; T Niikura; H Tajima; T Yasukawa; H Sudo; Y Ito; Y Kita; M Kawasumi; K Kouyama; M Doyu; G Sobue; T Koide; S Tsuji; J Lang; K Kurokawa; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults.

Authors:  Y Hashimoto; T Niikura; Y Ito; H Sudo; M Hata; E Arakawa; Y Abe; Y Kita; I Nishimoto
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.

Authors:  R Siman; A G Reaume; M J Savage; S Trusko; Y G Lin; R W Scott; D G Flood
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice.

Authors:  R Amson; J M Lassalle; H Halley; S Prieur; F Lethrosne; J P Roperch; D Israeli; M C Gendron; C Duyckaerts; F Checler; J Dausset; D Cohen; M Oren; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Transgenic modifications of the rat genome.

Authors:  Laurent Tesson; Jean Cozzi; Séverine Ménoret; Séverine Rémy; Claire Usal; Alexandre Fraichard; Ignacio Anegon
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

6.  Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.

Authors:  M Grilli; E Diodato; G Lozza; R Brusa; M Casarini; D Uberti; R Rozmahel; D Westaway; P St George-Hyslop; M Memo; E Ongini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's APP mutation and sensitizes cells to staurosporine-induced cell death.

Authors:  Steffen Leutz; Barbara Steiner; Celio A Marques; Christian Haass; Walter E Müller; Anne Eckert
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

8.  Alterations in presenilin 1 processing by amyloid-beta peptide in the rat retina.

Authors:  Helena R Watts; Valerie Vince; Desmond T Walsh; Laura G Bresciani; Stephen M Gentleman; Ling-Sun Jen; Peter J B Anderson
Journal:  Exp Brain Res       Date:  2007-02-28       Impact factor: 2.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.